Vogt Sebastian, Ruppert Volker, Pankuweit Sabine, Paletta Jürgen P J, Rhiel Annika, Weber Petra, Irqsusi Marc, Cybulski Pia, Ramzan Rabia
Cardiovascular Research Laboratories at the Biochemical Pharmacological Center, Philipps-University Marburg and Universitätsklinikum Gießen and Marburg GmbH, Marburg, Germany.
Heart Surgery, Philipps-University Marburg and Universitätsklinikum Gießen and Marburg GmbH, Marburg, Germany.
J Cardiothorac Surg. 2018 Sep 17;13(1):95. doi: 10.1186/s13019-018-0785-7.
Treatment of heart failure remains one of the most challenging task for intensive care medicine, cardiology and cardiac surgery. New options and better indicators are always required. Understanding the basic mechanisms underlying heart failure promote the development of adjusted therapy e.g. assist devices and monitoring of recovery. If cardiac failure is related to compromised cellular respiration of the heart, remains unclear. Myocardial respiration depends on Cytochrome c- Oxidase (CytOx) activity representing the rate limiting step for the mitochondrial respiratory chain. The enzymatic activity as well as mRNA expression of enzyme's mitochondrial encoded catalytic subunit 2, nuclear encoded regulatory subunit 4 and protein contents were studied in biopsies of cardiac patients suffering from myocardial insufficiency and dilated cardiomyopathy (DCM).
Fifty-four patients were enrolled in the study and underwent coronary angiography. Thirty male patients (mean age: 45 +/- 15 yrs.) had a reduced ejection fraction (EF) 35 ± 12% below 45% and a left ventricular end diastolic diameter (LVEDD) of 71 ± 10 mm bigger than 56 mm. They were diagnosed as having idiopathic dilated cardiomyopathy (DCM) without coronary heart disease and NYHA-class 3 and 4. Additionally, 24 male patients (mean age: 52 +/- 11 yrs.) after exclusion of secondary cardiomyopathies, coronary artery or valve disease, served as control (EF: 68 ± 7, LVEDD: 51 ± 7 mm). Total RNA was extracted from two biopsies of each person. Real-time PCR analysis was performed with specific primers followed by a melt curve analysis. Corresponding protein expression in the tissue was studied with immune-histochemistry while enzymatic activity was evaluated by spectroscopy.
Gene and protein expression analysis of patients showed a significant decrease of subunit 4 (1.1 vs. 0.6, p < 0.001; 7.7 ± 3.1% vs. 2.8 ± 1.4%, p < 0.0001) but no differences in subunit 2. Correlations were found between reduced subunit 2 expression, low EF (r = 0.766, p < 0.00045) and increased LVEDD (r = 0.492, p < 0.0068). In case of DCM less subunit 4 expression and reduced shortening fraction (r = 0.524, p < 0.017) was found, but enzymatic activity was higher (0.08 ± 0.06 vs. 0.26 ± 0.08 U/mg, p < 0.001) although myocardial oxygen consumption continued to the same extent.
In case of myocardial insufficiency and DCM, decreased expression of COX 4 results in an impaired CytOx activity. Higher enzymatic activity but equal oxygen consumption contribute to the pathophysiology of the myocardial insufficiency and appears as an indicator of oxidative stress. This kind of dysregulation should be in the focus for the development of diagnostic and therapy procedures.
心力衰竭的治疗仍然是重症医学、心脏病学和心脏外科面临的最具挑战性的任务之一。始终需要新的治疗选择和更好的指标。了解心力衰竭的基本机制有助于调整治疗方法的发展,如辅助装置和恢复监测。心力衰竭是否与心脏细胞呼吸受损有关尚不清楚。心肌呼吸依赖于细胞色素c氧化酶(CytOx)的活性,它代表线粒体呼吸链的限速步骤。在患有心肌功能不全和扩张型心肌病(DCM)的心脏病患者的活检组织中,研究了该酶的线粒体编码催化亚基2、核编码调节亚基4的酶活性、mRNA表达和蛋白质含量。
54例患者纳入本研究并接受冠状动脉造影。30例男性患者(平均年龄:45±15岁)射血分数(EF)降低至35±12%,低于45%,左心室舒张末期内径(LVEDD)为71±10mm,大于56mm。他们被诊断为特发性扩张型心肌病(DCM),无冠心病,纽约心脏协会(NYHA)心功能分级为3级和4级。另外,24例男性患者(平均年龄:52±11岁)在排除继发性心肌病、冠状动脉或瓣膜疾病后作为对照(EF:68±7,LVEDD:51±7mm)。从每个人的两份活检组织中提取总RNA。使用特异性引物进行实时PCR分析,随后进行熔解曲线分析。用免疫组织化学研究组织中的相应蛋白表达,同时通过光谱法评估酶活性。
患者的基因和蛋白表达分析显示亚基4显著降低(1.1对0.6,p<0.001;7.7±3.1%对2.8±1.4%,p<0.0001),但亚基2无差异。亚基2表达降低与低EF(r=0.766,p<0.00045)和LVEDD增加(r=0.492,p<0.0068)之间存在相关性。在DCM患者中,发现亚基4表达减少和缩短分数降低(r=0.524,p<0.017),但酶活性较高(0.08±0.06对0.26±0.08U/mg,p<0.001),尽管心肌耗氧量持续在相同水平。
在心肌功能不全和DCM患者中,COX 4表达降低导致CytOx活性受损。较高的酶活性但相同的耗氧量促成了心肌功能不全的病理生理学过程,并表现为氧化应激的一个指标。这种失调应成为诊断和治疗程序发展的重点。